The Silent Saboteur: Confronting Fatty Liver Disease

Hepatic steatosis is a common, complex metabolic disease characterized by the buildup of excess fat within liver cells. It is the early state of a condition known as nonalcoholic fatty liver disease (NAFLD) and is the most common liver disorder in industrialized countries with increasing prevalence noted alongside the global epidemic of obesity.

An estimated 25-33% of adults in the United States have fatty liver disease. In the adolescent and young adult population, the prevalence of fatty liver is increasing and estimated at 18.5%. NAFLD is often without symptoms and detected only after incidental laboratory or radiology findings.

Read the full article at City Lifestyle here.